Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-26 @ 2:32 AM
NCT ID:
NCT00778102
Group ID:
EG001
Title:
Bevacizumab + FOLFOXIRI
Description:
Participants received a chemotherapy regimen of bevacizumab plus FOLFOXIRI. Each drug was administered on Day 1 of each 2-week cycle. Dosing was as follows: bevacizumab 5 mg/kg via IV infusion; oxaliplatin 85 mg/m\^2 via IV infusion; irinotecan 165 mg/m\^2 via IV infusion; leucovorin 200 mg/m\^2 via IV infusion; and 5-FU 3200 mg/m\^2 via continuous 46-hour IV infusion. Following completion of 12 cycles, participants were to discontinue either irinotecan, oxaliplatin, or both. Treatment was continued until resectability, PD, unacceptable toxicity, or participant refusal.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
24
Serious Number At Risk:
40
Other Number Affected:
40
Other Number At Risk:
40
Study:
NCT00778102
Results Section:
NCT00778102
Adverse Events Module:
NCT00778102